📷 Image: Wikimedia Commons / Shamirpetwala
Health
Supreme Court Dismisses Plea Challenging Homeopathic Immunity Booster in Kerala
✍️ Business Standard
🗓 22 Aug 2026, 05:10 AM
👁 7
The Supreme Court has rejected a petition seeking to halt the use of a homeopathic product marketed as an immunity booster in Kerala, allowing its continued availability.
The Supreme Court bench has refused to entertain a petition that aimed to stop the distribution of a homeopathic preparation promoted as an immunity booster in Kerala. By dismissing the plea, the court has left the product's status unchanged, permitting its continued sale and use in the state.
The petitioners argued that the product lacked scientific validation and could mislead the public, seeking an injunction against its marketing. The court, however, found insufficient grounds to interfere with the state's health initiatives and therefore declined to grant the relief sought.
Legal experts note that the decision underscores the judiciary's cautious approach when health‑related claims intersect with alternative medicine practices. The ruling maintains the existing regulatory framework for homeopathic remedies in Kerala, pending any further evidence or policy revisions.
Consumers are advised to consult qualified medical professionals before relying on any immunity‑boosting product, especially those lacking robust clinical evidence.
The petitioners argued that the product lacked scientific validation and could mislead the public, seeking an injunction against its marketing. The court, however, found insufficient grounds to interfere with the state's health initiatives and therefore declined to grant the relief sought.
Legal experts note that the decision underscores the judiciary's cautious approach when health‑related claims intersect with alternative medicine practices. The ruling maintains the existing regulatory framework for homeopathic remedies in Kerala, pending any further evidence or policy revisions.
Consumers are advised to consult qualified medical professionals before relying on any immunity‑boosting product, especially those lacking robust clinical evidence.